{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:22Z","timestamp":1786979962360,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["#2016\/20371-1"],"award-info":[{"award-number":["#2016\/20371-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2015\/12628-0"],"award-info":[{"award-number":["2015\/12628-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00296-018-4215-x","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T03:00:27Z","timestamp":1543978827000},"page":"311-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5207-7603","authenticated-orcid":false,"given":"Isabela Bruna Pires","family":"Borges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-4517","authenticated-orcid":false,"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"4215_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"4215_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.coph.2010.03.001","volume":"10","author":"MC Dalakas","year":"2010","unstructured":"Dalakas MC (2010) Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol 10:346\u2013352","journal-title":"Curr Opin Pharmacol"},{"key":"4215_CR3","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372:1734\u20131747","journal-title":"N Engl J Med"},{"key":"4215_CR4","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964","journal-title":"Ann Rheum Dis"},{"key":"4215_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/acr.21879","volume":"65","author":"MT Moraes","year":"2013","unstructured":"Moraes MT, Souza FH, Barros TB et al (2013) An analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. Arthritis Care Res 65:793\u2013799","journal-title":"Arthritis Care Res"},{"key":"4215_CR6","first-page":"82","volume":"32","author":"FHC Souza","year":"2014","unstructured":"Souza FHC, Shinjo SK (2014) High prevalence of metabolic syndrome in polymyositis. Clin Exp Rheumatol 32:82\u201387","journal-title":"Clin Exp Rheumatol"},{"key":"4215_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.6061\/clinics\/2016(12)06","volume":"71","author":"MG Silva","year":"2016","unstructured":"Silva MG, Borba EF, Mello SB et al (2016) Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients. Clinics 71:709\u2013714","journal-title":"Clinics"},{"key":"4215_CR8","first-page":"241","volume":"36","author":"PAO Araujo","year":"2018","unstructured":"Araujo PAO, Silva MG, Borba EF et al (2018) High prevalence of metabolic syndrome in antisynthetase syndrome. Clin Exp Rheumatol 36:241\u2013247","journal-title":"Clin Exp Rheumatol"},{"key":"4215_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2011.11.005","volume":"222","author":"S Padala","year":"2012","unstructured":"Padala S, Thompson PD (2012) Statins as a possible cause of inflammatory and necrotizing myopathies. Atherosclerosis 222:15\u201321","journal-title":"Atherosclerosis"},{"key":"4215_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S et al (2005) Mild to moderate muscular symptoms with high-dose statin therapy in hyperlipidemic patients\u2014the PRIMO study. Cardiovasc Drugs Ther 19:403\u2013414","journal-title":"Cardiovasc Drugs Ther"},{"key":"4215_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","volume":"17","author":"M Needham","year":"2007","unstructured":"Needham M, Fabian V, Knezevic W et al (2007) Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord 17:194\u2013200","journal-title":"Neuromuscul Disord"},{"key":"4215_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L et al (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheumatol 63:713\u2013721","journal-title":"Arthritis Rheumatol"},{"key":"4215_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","volume":"15","author":"L Musset","year":"2016","unstructured":"Musset L, Allenbach Y, Benveniste O et al (2016) Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study. Autoimmun Rev 15:983\u2013993","journal-title":"Autoimmun Rev"},{"key":"4215_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/BOR.0000000000000335","volume":"28","author":"I Pinal-Fernandez","year":"2016","unstructured":"Pinal-Fernandez I, Mammen AL (2016) Spectrum of immune-mediated necrotizing myopathies and their treatments. Curr Opin Rheumatol 28:619\u2013624","journal-title":"Curr Opin Rheumatol"},{"key":"4215_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jacc.2016.04.037","volume":"68","author":"P Basharat","year":"2016","unstructured":"Basharat P, Lahouti AH, Paik JJ et al (2016) Statin-induced anti-HMGCR-associated myopathy. J Am Coll Cardiol 68:234\u2013235","journal-title":"J Am Coll Cardiol"},{"key":"4215_CR16","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1001\/jamainternmed.2018.2859","volume":"178","author":"GE Caughey","year":"2018","unstructured":"Caughey GE, Gabb GM, Ronson S, Ward M (2018) Association of statin exposure with histologically confirmed idiopathic inflammatory myositis in an Australian population. JAMA Intern Med 178:1224\u20131229","journal-title":"JAMA Intern Med"},{"key":"4215_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00296-017-3821-3","volume":"38","author":"IBP Borges","year":"2018","unstructured":"Borges IBP, Silva MG, Misse RG et al (2018) Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatol Int 38:293\u2013301","journal-title":"Rheumatol Int"},{"key":"4215_CR18","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV et al (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138:1464\u20131474","journal-title":"Chest"},{"key":"4215_CR19","volume-title":"Aids to the examination of the peripheral nervous system, Memorandum no. 45","author":"Medical Research Council","year":"1981","unstructured":"Medical Research Council (1981) Aids to the examination of the peripheral nervous system, Memorandum no. 45. Her Majesty\u2019s Stationery Office, London"},{"key":"4215_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","volume":"68","author":"MG Cruellas","year":"2013","unstructured":"Cruellas MG, Viana VS, Levy-Neto M et al (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics 68:909\u2013914","journal-title":"Clinics"},{"key":"4215_CR21","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","volume":"288","author":"HM Lakka","year":"2002","unstructured":"Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709\u20132716","journal-title":"JAMA"},{"key":"4215_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2337\/diacare.26.3.575","volume":"26","author":"ES Ford","year":"2003","unstructured":"Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575\u2013581","journal-title":"Diabetes Care"},{"key":"4215_CR23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10067-012-1986-4","volume":"31","author":"C Charles-Schoeman","year":"2012","unstructured":"Charles-Schoeman C, Amjadi SS, Paulus HE, for the International Myositis Assessment and Clinical Studies Group (2012) Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey. Clin Rheumatol 31:1163\u20131168","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4215-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T19:14:09Z","timestamp":1575486849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4215-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4215"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4215-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The present study was approved by the local ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}